0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Porcine Circovirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-32L285
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Porcine Circovirus Vaccine Market Professional Survey Report 2019
BUY CHAPTERS

Porcine Circovirus Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-32L285
Report
September 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Porcine Circovirus Vaccine - Market Size

The global market for Porcine Circovirus Vaccine was estimated to be worth US$ 245 million in 2023 and is forecast to a readjusted size of US$ 409 million by 2030 with a CAGR of 7.5% during the forecast period 2024-2030

Porcine Circovirus Vaccine - Market

Porcine Circovirus Vaccine - Market

Porcine circovirus (PCV) is a group of single-stranded DNA viruses (class II), that is nonenveloped with an unsegmented circular genome.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Porcine Circovirus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Porcine Circovirus Vaccine by region & country, by Type, and by Application.
The Porcine Circovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Porcine Circovirus Vaccine.
Market Segmentation

Scope of Porcine Circovirus Vaccine - Market Report

Report Metric Details
Report Name Porcine Circovirus Vaccine - Market
Forecasted market size in 2030 US$ 409 million
CAGR 7.5%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Piglets
  • Adults Pigs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Chopper Biology, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Jinyu Bio-Technology, Zoetis, Boehringer Ingelheim
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Porcine Circovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Porcine Circovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Porcine Circovirus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Porcine Circovirus Vaccine - Market size in 2030?

Ans: The Porcine Circovirus Vaccine - Market size in 2030 will be US$ 409 million.

Who are the main players in the Porcine Circovirus Vaccine - Market report?

Ans: The main players in the Porcine Circovirus Vaccine - Market are Chopper Biology, ChengDu Tecbond, Ringpu Biology, Qilu Animal, DHN, CAVAC, Komipharm, Jinyu Bio-Technology, Zoetis, Boehringer Ingelheim

What are the Application segmentation covered in the Porcine Circovirus Vaccine - Market report?

Ans: The Applications covered in the Porcine Circovirus Vaccine - Market report are Piglets, Adults Pigs

What are the Type segmentation covered in the Porcine Circovirus Vaccine - Market report?

Ans: The Types covered in the Porcine Circovirus Vaccine - Market report are Genetic Engineering Vaccine, Killed Vaccines

Recommended Reports

Livestock Vaccines

Human Vaccines

Innovative Vaccine Technologies

1 Market Overview
1.1 Porcine Circovirus Vaccine Product Introduction
1.2 Global Porcine Circovirus Vaccine Market Size Forecast
1.2.1 Global Porcine Circovirus Vaccine Sales Value (2019-2030)
1.2.2 Global Porcine Circovirus Vaccine Sales Volume (2019-2030)
1.2.3 Global Porcine Circovirus Vaccine Sales Price (2019-2030)
1.3 Porcine Circovirus Vaccine Market Trends & Drivers
1.3.1 Porcine Circovirus Vaccine Industry Trends
1.3.2 Porcine Circovirus Vaccine Market Drivers & Opportunity
1.3.3 Porcine Circovirus Vaccine Market Challenges
1.3.4 Porcine Circovirus Vaccine Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Porcine Circovirus Vaccine Players Revenue Ranking (2023)
2.2 Global Porcine Circovirus Vaccine Revenue by Company (2019-2024)
2.3 Global Porcine Circovirus Vaccine Players Sales Volume Ranking (2023)
2.4 Global Porcine Circovirus Vaccine Sales Volume by Company Players (2019-2024)
2.5 Global Porcine Circovirus Vaccine Average Price by Company (2019-2024)
2.6 Key Manufacturers Porcine Circovirus Vaccine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Porcine Circovirus Vaccine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Porcine Circovirus Vaccine
2.9 Porcine Circovirus Vaccine Market Competitive Analysis
2.9.1 Porcine Circovirus Vaccine Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Porcine Circovirus Vaccine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Circovirus Vaccine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genetic Engineering Vaccine
3.1.2 Killed Vaccines
3.2 Global Porcine Circovirus Vaccine Sales Value by Type
3.2.1 Global Porcine Circovirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Porcine Circovirus Vaccine Sales Value, by Type (2019-2030)
3.2.3 Global Porcine Circovirus Vaccine Sales Value, by Type (%) (2019-2030)
3.3 Global Porcine Circovirus Vaccine Sales Volume by Type
3.3.1 Global Porcine Circovirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Porcine Circovirus Vaccine Sales Volume, by Type (2019-2030)
3.3.3 Global Porcine Circovirus Vaccine Sales Volume, by Type (%) (2019-2030)
3.4 Global Porcine Circovirus Vaccine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adults Pigs
4.2 Global Porcine Circovirus Vaccine Sales Value by Application
4.2.1 Global Porcine Circovirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Porcine Circovirus Vaccine Sales Value, by Application (2019-2030)
4.2.3 Global Porcine Circovirus Vaccine Sales Value, by Application (%) (2019-2030)
4.3 Global Porcine Circovirus Vaccine Sales Volume by Application
4.3.1 Global Porcine Circovirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Porcine Circovirus Vaccine Sales Volume, by Application (2019-2030)
4.3.3 Global Porcine Circovirus Vaccine Sales Volume, by Application (%) (2019-2030)
4.4 Global Porcine Circovirus Vaccine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Porcine Circovirus Vaccine Sales Value by Region
5.1.1 Global Porcine Circovirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Porcine Circovirus Vaccine Sales Value by Region (2019-2024)
5.1.3 Global Porcine Circovirus Vaccine Sales Value by Region (2025-2030)
5.1.4 Global Porcine Circovirus Vaccine Sales Value by Region (%), (2019-2030)
5.2 Global Porcine Circovirus Vaccine Sales Volume by Region
5.2.1 Global Porcine Circovirus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Porcine Circovirus Vaccine Sales Volume by Region (2019-2024)
5.2.3 Global Porcine Circovirus Vaccine Sales Volume by Region (2025-2030)
5.2.4 Global Porcine Circovirus Vaccine Sales Volume by Region (%), (2019-2030)
5.3 Global Porcine Circovirus Vaccine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Porcine Circovirus Vaccine Sales Value, 2019-2030
5.4.2 North America Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Porcine Circovirus Vaccine Sales Value, 2019-2030
5.5.2 Europe Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Porcine Circovirus Vaccine Sales Value, 2019-2030
5.6.2 Asia Pacific Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Porcine Circovirus Vaccine Sales Value, 2019-2030
5.7.2 South America Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Porcine Circovirus Vaccine Sales Value, 2019-2030
5.8.2 Middle East & Africa Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Porcine Circovirus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Porcine Circovirus Vaccine Sales Value
6.2.1 Key Countries/Regions Porcine Circovirus Vaccine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Porcine Circovirus Vaccine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Porcine Circovirus Vaccine Sales Value, 2019-2030
6.3.2 United States Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Porcine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Porcine Circovirus Vaccine Sales Value, 2019-2030
6.4.2 Europe Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Porcine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Porcine Circovirus Vaccine Sales Value, 2019-2030
6.5.2 China Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Porcine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Porcine Circovirus Vaccine Sales Value, 2019-2030
6.6.2 Japan Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Porcine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Porcine Circovirus Vaccine Sales Value, 2019-2030
6.7.2 South Korea Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Porcine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Porcine Circovirus Vaccine Sales Value, 2019-2030
6.8.2 Southeast Asia Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Porcine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Porcine Circovirus Vaccine Sales Value, 2019-2030
6.9.2 India Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Porcine Circovirus Vaccine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Chopper Biology
7.1.1 Chopper Biology Company Information
7.1.2 Chopper Biology Introduction and Business Overview
7.1.3 Chopper Biology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Chopper Biology Porcine Circovirus Vaccine Product Offerings
7.1.5 Chopper Biology Recent Development
7.2 ChengDu Tecbond
7.2.1 ChengDu Tecbond Company Information
7.2.2 ChengDu Tecbond Introduction and Business Overview
7.2.3 ChengDu Tecbond Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ChengDu Tecbond Porcine Circovirus Vaccine Product Offerings
7.2.5 ChengDu Tecbond Recent Development
7.3 Ringpu Biology
7.3.1 Ringpu Biology Company Information
7.3.2 Ringpu Biology Introduction and Business Overview
7.3.3 Ringpu Biology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Ringpu Biology Porcine Circovirus Vaccine Product Offerings
7.3.5 Ringpu Biology Recent Development
7.4 Qilu Animal
7.4.1 Qilu Animal Company Information
7.4.2 Qilu Animal Introduction and Business Overview
7.4.3 Qilu Animal Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Qilu Animal Porcine Circovirus Vaccine Product Offerings
7.4.5 Qilu Animal Recent Development
7.5 DHN
7.5.1 DHN Company Information
7.5.2 DHN Introduction and Business Overview
7.5.3 DHN Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 DHN Porcine Circovirus Vaccine Product Offerings
7.5.5 DHN Recent Development
7.6 CAVAC
7.6.1 CAVAC Company Information
7.6.2 CAVAC Introduction and Business Overview
7.6.3 CAVAC Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 CAVAC Porcine Circovirus Vaccine Product Offerings
7.6.5 CAVAC Recent Development
7.7 Komipharm
7.7.1 Komipharm Company Information
7.7.2 Komipharm Introduction and Business Overview
7.7.3 Komipharm Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Komipharm Porcine Circovirus Vaccine Product Offerings
7.7.5 Komipharm Recent Development
7.8 Jinyu Bio-Technology
7.8.1 Jinyu Bio-Technology Company Information
7.8.2 Jinyu Bio-Technology Introduction and Business Overview
7.8.3 Jinyu Bio-Technology Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jinyu Bio-Technology Porcine Circovirus Vaccine Product Offerings
7.8.5 Jinyu Bio-Technology Recent Development
7.9 Zoetis
7.9.1 Zoetis Company Information
7.9.2 Zoetis Introduction and Business Overview
7.9.3 Zoetis Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Zoetis Porcine Circovirus Vaccine Product Offerings
7.9.5 Zoetis Recent Development
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Company Information
7.10.2 Boehringer Ingelheim Introduction and Business Overview
7.10.3 Boehringer Ingelheim Porcine Circovirus Vaccine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Boehringer Ingelheim Porcine Circovirus Vaccine Product Offerings
7.10.5 Boehringer Ingelheim Recent Development
8 Industry Chain Analysis
8.1 Porcine Circovirus Vaccine Industrial Chain
8.2 Porcine Circovirus Vaccine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Porcine Circovirus Vaccine Sales Model
8.5.2 Sales Channel
8.5.3 Porcine Circovirus Vaccine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Porcine Circovirus Vaccine Market Trends
    Table 2. Porcine Circovirus Vaccine Market Drivers & Opportunity
    Table 3. Porcine Circovirus Vaccine Market Challenges
    Table 4. Porcine Circovirus Vaccine Market Restraints
    Table 5. Global Porcine Circovirus Vaccine Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Porcine Circovirus Vaccine Revenue Market Share by Company (2019-2024)
    Table 7. Global Porcine Circovirus Vaccine Sales Volume by Company (2019-2024) & (M Units)
    Table 8. Global Porcine Circovirus Vaccine Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Porcine Circovirus Vaccine Price by Company (2019-2024) & (USD/K Unit)
    Table 10. Key Manufacturers Porcine Circovirus Vaccine Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Porcine Circovirus Vaccine Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Porcine Circovirus Vaccine
    Table 13. Global Porcine Circovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porcine Circovirus Vaccine as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Porcine Circovirus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Porcine Circovirus Vaccine Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Porcine Circovirus Vaccine Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Porcine Circovirus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Porcine Circovirus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Porcine Circovirus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)
    Table 22. Global Porcine Circovirus Vaccine Sales Volume by Type (2019-2024) & (M Units)
    Table 23. Global Porcine Circovirus Vaccine Sales Volume by Type (2025-2030) & (M Units)
    Table 24. Global Porcine Circovirus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Porcine Circovirus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Porcine Circovirus Vaccine Price by Type (2019-2024) & (USD/K Unit)
    Table 27. Global Porcine Circovirus Vaccine Price by Type (2025-2030) & (USD/K Unit)
    Table 28. Global Porcine Circovirus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Porcine Circovirus Vaccine Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Porcine Circovirus Vaccine Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Porcine Circovirus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Porcine Circovirus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Porcine Circovirus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)
    Table 34. Global Porcine Circovirus Vaccine Sales Volume by Application (2019-2024) & (M Units)
    Table 35. Global Porcine Circovirus Vaccine Sales Volume by Application (2025-2030) & (M Units)
    Table 36. Global Porcine Circovirus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Porcine Circovirus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Porcine Circovirus Vaccine Price by Application (2019-2024) & (USD/K Unit)
    Table 39. Global Porcine Circovirus Vaccine Price by Application (2025-2030) & (USD/K Unit)
    Table 40. Global Porcine Circovirus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Porcine Circovirus Vaccine Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Porcine Circovirus Vaccine Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Porcine Circovirus Vaccine Sales Value by Region (2019-2024) & (%)
    Table 44. Global Porcine Circovirus Vaccine Sales Value by Region (2025-2030) & (%)
    Table 45. Global Porcine Circovirus Vaccine Sales Volume by Region (M Units): 2019 VS 2023 VS 2030
    Table 46. Global Porcine Circovirus Vaccine Sales Volume by Region (2019-2024) & (M Units)
    Table 47. Global Porcine Circovirus Vaccine Sales Volume by Region (2025-2030) & (M Units)
    Table 48. Global Porcine Circovirus Vaccine Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Porcine Circovirus Vaccine Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Porcine Circovirus Vaccine Average Price by Region (2019-2024) & (USD/K Unit)
    Table 51. Global Porcine Circovirus Vaccine Average Price by Region (2025-2030) & (USD/K Unit)
    Table 52. Key Countries/Regions Porcine Circovirus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Porcine Circovirus Vaccine Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Porcine Circovirus Vaccine Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Porcine Circovirus Vaccine Sales Volume, (2019-2024) & (M Units)
    Table 56. Key Countries/Regions Porcine Circovirus Vaccine Sales Volume, (2025-2030) & (M Units)
    Table 57. Chopper Biology Company Information
    Table 58. Chopper Biology Introduction and Business Overview
    Table 59. Chopper Biology Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 60. Chopper Biology Porcine Circovirus Vaccine Product Offerings
    Table 61. Chopper Biology Recent Development
    Table 62. ChengDu Tecbond Company Information
    Table 63. ChengDu Tecbond Introduction and Business Overview
    Table 64. ChengDu Tecbond Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 65. ChengDu Tecbond Porcine Circovirus Vaccine Product Offerings
    Table 66. ChengDu Tecbond Recent Development
    Table 67. Ringpu Biology Company Information
    Table 68. Ringpu Biology Introduction and Business Overview
    Table 69. Ringpu Biology Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 70. Ringpu Biology Porcine Circovirus Vaccine Product Offerings
    Table 71. Ringpu Biology Recent Development
    Table 72. Qilu Animal Company Information
    Table 73. Qilu Animal Introduction and Business Overview
    Table 74. Qilu Animal Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 75. Qilu Animal Porcine Circovirus Vaccine Product Offerings
    Table 76. Qilu Animal Recent Development
    Table 77. DHN Company Information
    Table 78. DHN Introduction and Business Overview
    Table 79. DHN Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 80. DHN Porcine Circovirus Vaccine Product Offerings
    Table 81. DHN Recent Development
    Table 82. CAVAC Company Information
    Table 83. CAVAC Introduction and Business Overview
    Table 84. CAVAC Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 85. CAVAC Porcine Circovirus Vaccine Product Offerings
    Table 86. CAVAC Recent Development
    Table 87. Komipharm Company Information
    Table 88. Komipharm Introduction and Business Overview
    Table 89. Komipharm Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 90. Komipharm Porcine Circovirus Vaccine Product Offerings
    Table 91. Komipharm Recent Development
    Table 92. Jinyu Bio-Technology Company Information
    Table 93. Jinyu Bio-Technology Introduction and Business Overview
    Table 94. Jinyu Bio-Technology Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 95. Jinyu Bio-Technology Porcine Circovirus Vaccine Product Offerings
    Table 96. Jinyu Bio-Technology Recent Development
    Table 97. Zoetis Company Information
    Table 98. Zoetis Introduction and Business Overview
    Table 99. Zoetis Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 100. Zoetis Porcine Circovirus Vaccine Product Offerings
    Table 101. Zoetis Recent Development
    Table 102. Boehringer Ingelheim Company Information
    Table 103. Boehringer Ingelheim Introduction and Business Overview
    Table 104. Boehringer Ingelheim Porcine Circovirus Vaccine Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 105. Boehringer Ingelheim Porcine Circovirus Vaccine Product Offerings
    Table 106. Boehringer Ingelheim Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Porcine Circovirus Vaccine Downstream Customers
    Table 110. Porcine Circovirus Vaccine Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Porcine Circovirus Vaccine Product Picture
    Figure 2. Global Porcine Circovirus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Porcine Circovirus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Porcine Circovirus Vaccine Sales Volume (2019-2030) & (M Units)
    Figure 5. Global Porcine Circovirus Vaccine Sales Price (2019-2030) & (USD/K Unit)
    Figure 6. Porcine Circovirus Vaccine Report Years Considered
    Figure 7. Global Porcine Circovirus Vaccine Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Porcine Circovirus Vaccine Players Sales Volume Ranking (2023) & (M Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Porcine Circovirus Vaccine Revenue in 2023
    Figure 10. Porcine Circovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Genetic Engineering Vaccine Picture
    Figure 12. Killed Vaccines Picture
    Figure 13. Global Porcine Circovirus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Porcine Circovirus Vaccine Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Porcine Circovirus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)
    Figure 16. Global Porcine Circovirus Vaccine Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Porcine Circovirus Vaccine Price by Type (2019-2030) & (USD/K Unit)
    Figure 18. Product Picture of Piglets
    Figure 19. Product Picture of Adults Pigs
    Figure 20. Global Porcine Circovirus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Porcine Circovirus Vaccine Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Porcine Circovirus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)
    Figure 23. Global Porcine Circovirus Vaccine Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Porcine Circovirus Vaccine Price by Application (2019-2030) & (USD/K Unit)
    Figure 25. North America Porcine Circovirus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Porcine Circovirus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Porcine Circovirus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Porcine Circovirus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Porcine Circovirus Vaccine Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Porcine Circovirus Vaccine Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Porcine Circovirus Vaccine Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Porcine Circovirus Vaccine Sales Volume (%), (2019-2030)
    Figure 37. United States Porcine Circovirus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Porcine Circovirus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Porcine Circovirus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Porcine Circovirus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Porcine Circovirus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Porcine Circovirus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Porcine Circovirus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Porcine Circovirus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Porcine Circovirus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Porcine Circovirus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Porcine Circovirus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Porcine Circovirus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Porcine Circovirus Vaccine Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Porcine Circovirus Vaccine Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Porcine Circovirus Vaccine Sales Value by Application (%), 2023 VS 2030
    Figure 58. Porcine Circovirus Vaccine Industrial Chain
    Figure 59. Porcine Circovirus Vaccine Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS